Lumibird SA (LBIRD) - Total Assets
Based on the latest financial reports, Lumibird SA (LBIRD) holds total assets worth €435.94 Million EUR (≈ $509.66 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See LBIRD net asset value for net asset value and shareholders' equity analysis.
Lumibird SA - Total Assets Trend (2000–2024)
This chart illustrates how Lumibird SA's total assets have evolved over time, based on quarterly financial data.
Lumibird SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Lumibird SA's total assets of €435.94 Million consist of 48.6% current assets and 51.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €54.71 Million | 16.6% |
| Accounts Receivable | €58.85 Million | 13.7% |
| Inventory | €76.39 Million | 17.8% |
| Property, Plant & Equipment | €46.54 Million | 10.8% |
| Intangible Assets | €69.95 Million | 16.3% |
| Goodwill | €72.09 Million | 16.8% |
Asset Composition Trend (2000–2024)
This chart illustrates how Lumibird SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Lumibird SA (LBIRD) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lumibird SA's current assets represent 48.6% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 16.6% of total assets in 2024, up from 1.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, a decrease from 44.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 17.8% of total assets.
Lumibird SA Competitors by Total Assets
Key competitors of Lumibird SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Genetic Signatures Ltd
AU:GSS
|
Australia | AU$54.63 Million |
|
Leveljump Healthcare Corp
V:JUMP
|
Canada | CA$21.84 Million |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
Lumibird SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.61 | 2.68 | 3.43 |
| Quick Ratio | 1.63 | 1.61 | 2.49 |
| Cash Ratio | 0.53 | 0.60 | 0.00 |
| Working Capital | €136.79 Million | €125.84 Million | €113.89 Million |
Lumibird SA - Advanced Valuation Insights
This section examines the relationship between Lumibird SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.62 |
| Latest Market Cap to Assets Ratio | 1.19 |
| Asset Growth Rate (YoY) | 6.1% |
| Total Assets | €429.80 Million |
| Market Capitalization | $513.10 Million USD |
Valuation Analysis
Above Book Valuation: The market values Lumibird SA's assets above their book value (1.19x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Lumibird SA's assets grew by 6.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Lumibird SA (2000–2024)
The table below shows the annual total assets of Lumibird SA from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €429.80 Million ≈ $502.48 Million |
+6.06% |
| 2023-12-31 | €405.25 Million ≈ $473.78 Million |
+8.92% |
| 2022-12-31 | €372.04 Million ≈ $434.96 Million |
+7.03% |
| 2021-12-31 | €347.62 Million ≈ $406.41 Million |
+13.81% |
| 2020-12-31 | €305.43 Million ≈ $357.08 Million |
+57.64% |
| 2019-12-31 | €193.76 Million ≈ $226.52 Million |
+28.29% |
| 2018-12-31 | €151.03 Million ≈ $176.58 Million |
+24.74% |
| 2017-12-31 | €121.08 Million ≈ $141.55 Million |
+97.87% |
| 2016-12-31 | €61.19 Million ≈ $71.54 Million |
+0.13% |
| 2015-12-31 | €61.11 Million ≈ $71.44 Million |
+10.99% |
| 2014-12-31 | €55.06 Million ≈ $64.37 Million |
+6.92% |
| 2013-12-31 | €51.49 Million ≈ $60.20 Million |
-2.31% |
| 2012-12-31 | €52.71 Million ≈ $61.62 Million |
-9.57% |
| 2011-12-31 | €58.29 Million ≈ $68.15 Million |
+5.44% |
| 2010-12-31 | €55.28 Million ≈ $64.63 Million |
+0.94% |
| 2009-12-31 | €54.77 Million ≈ $64.03 Million |
-20.97% |
| 2008-12-31 | €69.30 Million ≈ $81.02 Million |
-0.15% |
| 2007-12-31 | €69.41 Million ≈ $81.14 Million |
+25.69% |
| 2006-12-31 | €55.22 Million ≈ $64.56 Million |
+25.76% |
| 2005-12-31 | €43.91 Million ≈ $51.34 Million |
+61.43% |
| 2004-12-31 | €27.20 Million ≈ $31.80 Million |
-3.42% |
| 2003-12-31 | €28.16 Million ≈ $32.92 Million |
-11.89% |
| 2002-12-31 | €31.96 Million ≈ $37.37 Million |
-3.89% |
| 2001-12-31 | €33.26 Million ≈ $38.88 Million |
-81.07% |
| 2000-12-31 | €175.71 Million ≈ $205.42 Million |
-- |
About Lumibird SA
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications. It operates in two divisions, Photonics and Medical. The company offers solid-state lasers, laser diodes and components, fiber lasers and amplifiers, and high-power fiber lasers; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military lasers rangefinders, and medical a… Read more